These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 28620050)

  • 21. Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation.
    Wei B; Gao X; Cadang L; Izadi S; Liu P; Zhang HM; Hecht E; Shim J; Magill G; Pabon JR; Dai L; Phung W; Lin E; Wang C; Whang K; Sanchez S; Oropeza J; Camperi J; Zhang J; Sandoval W; Zhang YT; Jiang G
    MAbs; 2021; 13(1):1893427. PubMed ID: 33682619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restricted motion of the conserved immunoglobulin G1 N-glycan is essential for efficient FcγRIIIa binding.
    Subedi GP; Hanson QM; Barb AW
    Structure; 2014 Oct; 22(10):1478-88. PubMed ID: 25199692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity.
    Thomann M; Schlothauer T; Dashivets T; Malik S; Avenal C; Bulau P; Rüger P; Reusch D
    PLoS One; 2015; 10(8):e0134949. PubMed ID: 26266936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choice of Host Cell Line Is Essential for the Functional Glycosylation of the Fc Region of Human IgG1 Inhibitors of Influenza B Viruses.
    Blundell PA; Lu D; Dell A; Haslam S; Pleass RJ
    J Immunol; 2020 Feb; 204(4):1022-1034. PubMed ID: 31907284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of intact glycopeptides reveals the impact of culture media on site-specific glycosylation of EPO-Fc fusion protein generated by CHO-GS cells.
    Wang Q; Yang G; Wang T; Yang W; Betenbaugh MJ; Zhang H
    Biotechnol Bioeng; 2019 Sep; 116(9):2303-2315. PubMed ID: 31062865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligosaccharide-protein interactions in IgG can modulate recognition by Fc gamma receptors.
    Lund J; Takahashi N; Pound JD; Goodall M; Nakagawa H; Jefferis R
    FASEB J; 1995 Jan; 9(1):115-9. PubMed ID: 7821750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
    Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
    MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of asparagine 330 deamidation in an Fc-fragment of IgG1 using cation exchange chromatography and peptide mapping.
    Zhang YT; Hu J; Pace AL; Wong R; Wang YJ; Kao YH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():65-71. PubMed ID: 24999246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition of IgG by Fcgamma receptor. The role of Fc glycosylation and the binding of peptide inhibitors.
    Radaev S; Sun PD
    J Biol Chem; 2001 May; 276(19):16478-83. PubMed ID: 11297533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
    Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
    Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain.
    Yu X; Vasiljevic S; Mitchell DA; Crispin M; Scanlan CN
    J Mol Biol; 2013 Apr; 425(8):1253-8. PubMed ID: 23416198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular dynamics simulation of the crystallizable fragment of IgG1-insights for the design of Fcabs.
    Lai B; Hasenhindl C; Obinger C; Oostenbrink C
    Int J Mol Sci; 2014 Jan; 15(1):438-55. PubMed ID: 24451126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered IgG1-Fc--one fragment to bind them all.
    Lobner E; Traxlmayr MW; Obinger C; Hasenhindl C
    Immunol Rev; 2016 Mar; 270(1):113-31. PubMed ID: 26864108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i.v. immunoglobulin.
    Sneed SL; Reese BB; Laureano AF; Ratnapriya S; Fraschilla I; Jeffrey KL; Coffey GP; Conley PB; Anthony RM
    J Clin Invest; 2024 Feb; 134(4):. PubMed ID: 38357917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
    Caaveiro JM; Kiyoshi M; Tsumoto K
    Immunol Rev; 2015 Nov; 268(1):201-21. PubMed ID: 26497522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition sites on human IgG for Fc gamma receptors: the role of glycosylation.
    Jefferis R; Lund J; Goodall M
    Immunol Lett; 1995 Jan; 44(2-3):111-7. PubMed ID: 7797239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functions.
    Crispin M; Bowden TA; Coles CH; Harlos K; Aricescu AR; Harvey DJ; Stuart DI; Jones EY
    J Mol Biol; 2009 Apr; 387(5):1061-6. PubMed ID: 19236877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Site-specific glycosylation of an aglycosylated human IgG1-Fc antibody protein generates neoglycoproteins with enhanced function.
    Watt GM; Lund J; Levens M; Kolli VS; Jefferis R; Boons GJ
    Chem Biol; 2003 Sep; 10(9):807-14. PubMed ID: 14522051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs.
    Anthony RM; Ravetch JV
    J Clin Immunol; 2010 May; 30 Suppl 1():S9-14. PubMed ID: 20480216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal antibodies.
    Yu X; Baruah K; Harvey DJ; Vasiljevic S; Alonzi DS; Song BD; Higgins MK; Bowden TA; Scanlan CN; Crispin M
    J Am Chem Soc; 2013 Jul; 135(26):9723-32. PubMed ID: 23745692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.